Stockscreener 앱 받기
15.60
1.70%
-0.27
시간 외 거래:
15.53
-0.07
-0.45%
Vor Biopharma Inc 주식(VOR)의 최신 뉴스
Ra Capital Management, L.P. Sells 530,610 Shares of Vor Biopharma (NASDAQ:VOR) Stock - MarketBeat
RA Capital sells Vor Biopharma (VOR) shares worth $11.8 million - Investing.com
Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 153,735 Shares of Stock - MarketBeat
Vor Biopharma (NASDAQ:VOR) Director Sells $858,840.44 in Stock - MarketBeat
RA Capital reports 19.9% Vor Biopharma (VOR) stake after share sales - Stock Titan
H.C. Wainwright lowers Vor Biopharma price target to $31 By Investing.com - Investing.com Australia
HC Wainwright Has Lowered Expectations for Vor Biopharma (NASDAQ:VOR) Stock Price - MarketBeat
VOR Maintains Buy Rating by HC Wainwright & Co. -- Price Target Lowered to $31 - GuruFocus
Vor Biopharma, Inc. (VOR) PT Lowered to $31 at H.C. Wainwright - StreetInsider
Vor Biopharma Inc. (NASDAQ:VOR) Short Interest Up 66.5% in March - MarketBeat
Vor Biopharma(VOR.US) 10% Shareholder Sells US$10.23 Million in Common Stock - Moomoo
Ra capital sells Vor Biopharma (VOR) shares worth $10.2 million By Investing.com - Investing.com India
Vor Biopharma (NASDAQ:VOR) Director Sells $2,242,984.59 in Stock - MarketBeat
Ra Capital Management, L.P. Sells 484,104 Shares of Vor Biopharma (NASDAQ:VOR) Stock - MarketBeat
Vor Biopharma (NASDAQ:VOR) Director Sells $13,041.00 in Stock - MarketBeat
Ra capital sells Vor Biopharma (VOR) shares worth $10.2 million - Investing.com
RA Capital trims Vor Biopharma (VOR) stake while keeping 19.9% ownership - Stock Titan
RA Capital Healthcare Fund trims Vor Biopharma (NASDAQ: VOR) stake, still holds 3.9M shares - Stock Titan
VOR Forecast, Price Target & Analyst Ratings | VOR BIOPHARMA INC (NASDAQ:VOR) - ChartMill
Vor Biopharma (VOR) Financials 2026Income Statement and Balance Sheet $VOR - MarketBeat
Vor Biopharma (VOR) CMO discloses options and RSU-based stake - Stock Titan
Dow Update: What are analysts price targets for Vor Biopharma IncEarnings Recap Report & Precise Trade Entry Recommendations - baoquankhu1.vn
RA Capital (NASDAQ: VOR) discloses 19.9% Vor Biopharma ownership cap - Stock Titan
Vor Biopharma: It's A Game Of Wait And See (NASDAQ:VOR) - Seeking Alpha
Bull Bear: What are analysts price targets for Vor Biopharma IncMarket Risk Summary & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Stifel reiterates Vor Biopharma stock rating on drug potential By Investing.com - Investing.com India
Stifel reiterates Vor Biopharma stock rating on drug potential - Investing.com
Vor Biopharma (VOR) Reiterated at Buy by Stifel After Meetings About Telitacicept Potential - StreetInsider
Aug Wrap: Should you buy the dip on Vor Biopharma Inc2026 Performance Recap & Fast Moving Market Watchlists - baoquankhu1.vn
Aug Momentum: Is Vor Biopharma Inc currently under institutional pressure2026 Recap & Daily Oversold Bounce Ideas - baoquankhu1.vn
Vor Biopharma (NASDAQ:VOR) Shares Gap Down on Insider Selling - MarketBeat
Vor Biopharma(VOR.US) 10% Shareholder Sells US$14.52 Million in Common Stock - Moomoo
Ra capital sells Vor Biopharma (VOR) shares worth $14.5 million By Investing.com - Investing.com Canada
Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 260,000 Shares of Stock - MarketBeat
Ra capital sells Vor Biopharma (VOR) shares worth $14.5 million - Investing.com
RA Capital trims Vor Biopharma (VOR) stake with 849K-share sale - Stock Titan
Vor Biopharma (NASDAQ:VOR) Trading Down 5.8%Here's Why - marketbeat.com
Wall Street analysts predict a 107.82% upside in Vor Biopharma (VOR): Here's what you should know - MSN
Vor Biopharma Inc. (NASDAQ:VOR) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 589,257 Shares of Stock - MarketBeat
Vor Biopharma (VOR) upgraded to buy: Here's why - MSN
Wall Street Zen Upgrades Vor Biopharma (NASDAQ:VOR) to Hold - MarketBeat
Jefferies initiates coverage of Vor Biopharma (VOR) with buy recommendation - MSN
Vor Biopharma (VOR) Upgraded to Buy: Here's Why - Yahoo Finance
Wall Street experts anticipate that Vor Biopharma (VOR) could surge by 107.82%: Key Information You Need to Know - bitget.com
Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know - Yahoo Finance
Chen Yu and TCG entities hold 10.5% of Vor Biopharma (NASDAQ: VOR) - Stock Titan
TCG Crossover funds in Vor (VOR) disclose 2,836,539 common shares - Stock Titan
Vor Biopharma (VOR) ownership update shows RA Capital at 19.9% - Stock Titan
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Vor Bio announces $75M private placement - MSN
Wedbush Maintains 'Neutral' Rating, Raises Price Target for Vor Biopharma (VOR) to $15 | VOR Stock News - gurufocus.com
2.69%
0.25%
자본화:
|
볼륨(24시간):